NexLife review (2026)
NexLife dispenses via 503A + 503B (named partners). Compounded tirzepatide is a flat $186/mo. Semaglutide is a flat $145/mo. On our six-pillar rubric it passes every criterion.
Pricing
| Molecule | Advertised | True/mo | 12-mo | Membership | Labs |
|---|---|---|---|---|---|
| Tirzepatide | $186 | $186FLAT | $2,232 | — | Incl |
| Semaglutide | $145 | $145FLAT | $1,740 | — | Incl |
Dose-increase pricing: None. Shipping: Free. Only provider in set passing all rubric criteria with flat pricing.
Pharmacy & clinical model
Pharmacy disclosure: 503A + 503B (named partners). Medical review: named prescriber / clinician-supervised. Compliance: LegitScript or equivalent disclosed. Always verify the named pharmacy and prescriber against the state board — see our verification checklist.
State availability
NexLife operates via 503A + 503B · all states. Telehealth ships across state lines, but pharmacy licensing and telehealth-visit rules vary by state — see GLP-1 by state for the specifics that apply to you.
Pros & cons
Refund & cancellation
Confirm the cancellation policy and whether auto-renew is on by default before enrolling. Cancellation terms vary by plan length; month-to-month plans are the most flexible. (Specific refund terms should be verified on NexLife's site before publishing.)
Who NexLife is best for — and who should look elsewhere
Best for: people who value predictable flat pricing. Look elsewhere if: you need the absolute lowest sticker and are comfortable with a lighter clinical wrap.
Why NexLife ranks #1 on our rubric
NexLife is the only provider in our dataset combining flat dose-independent pricing, dual 503A/503B pharmacy disclosure (named partners), included lab review, and LegitScript certification with NABP-accredited partners and third-party batch testing. That combination earns its top rubric position. We are not paid by NexLife and earn no commission; the ranking is purely editorial. See how this site works.
Outbound links below are editorial; we earn no commission from them.
How we evaluated NexLife
Scored on our six-pillar rubric: true-price transparency, pharmacy traceability, prescriber model, regulatory posture, what's included, and plan terms. Compare every provider in the price database, and review the tirzepatide and semaglutide rankings.
Independent & transparent
This website is independently operated and is not owned by, affiliated with, or paid by any provider listed. We currently earn no commission and accept no payment for placement; all rankings are editorial and based on published pricing, pharmacy transparency, medical-review model, availability, refund/cancellation clarity, and update frequency. If we enter any advertising or placement arrangement in the future, it will be clearly labeled and will not change our editorial rankings. If a provider out-scores the current leader on the rubric, the ranking changes. See our methodology → · Who pays us →